Neuroprotective Effects of Tocovid Pretreatment in a Mouse Stroke Model

Yang Jiao, Jingwei Shang, Yasuyuki Ohta, Hongjing Yan, Xia Liu, Xianghong Li, Ryuta Morihara, Yumiko Nakano, Yusuke Fukui, Xiaowen Shi, Yong Huang, Tian Feng, Mami Takemoto, Kota Sato, Nozomi Hishikawa, Toru Yamashita, Koji Abe

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: Tocovid is a new combination of tocotrienols and tocopherol, both of which are neuroprotective agents for preventing cerebral infarction in mice. However, the effects of tocovid on anti-inflammation in ischemic model remain elusive. In the present study, we assessed the effects of Tocovid pretreatment on anti-inflammatory effects after transient middle cerebral occlusion (tMCAO) in mice. Materials and Methods: We evaluated the therapeutic and anti-inflammatory effects of tocovid pretreatment (200 mg/kg per day, for 1 month) on mice brain under 60 minutes of tMCAO. The expressive changes of inflammatory markers were observed after tMCAO in mice. Results: Tocovid pretreatment greatly improved the mice neurobehaviors, reduced infarct volumes and decreased expressions of inflammatory markers such as tumor necrosis factor-α (TNF-α), monocyte chemotactic protein-1 (MCP-1) and ionized calcium binding adapter molecule-1 (Iba-1), and improved the damage of neurovascular units including matrix metallopeptidase 9, IgG and collagen IV after tMCAO. Conclusions: Our present findings demonstrated that oral tocovid pretreatment showed obviously neuroprotective and at least in part by anti-inflammatory effects in ischemic mice brain.

Original languageEnglish
JournalJournal of Stroke and Cerebrovascular Diseases
DOIs
Publication statusAccepted/In press - Jan 1 2018

Fingerprint

Neuroprotective Agents
Stroke
Anti-Inflammatory Agents
Tocotrienols
Tocopherols
Chemokine CCL2
Cerebral Infarction
Brain
Metalloproteases
Collagen
Tumor Necrosis Factor-alpha
Immunoglobulin G
Inflammation
Calcium

Keywords

  • Neuroinflammation
  • neurovascular unit dissociation
  • tocovid
  • transient middle cerebral occlusion

ASJC Scopus subject areas

  • Surgery
  • Rehabilitation
  • Clinical Neurology
  • Cardiology and Cardiovascular Medicine

Cite this

Neuroprotective Effects of Tocovid Pretreatment in a Mouse Stroke Model. / Jiao, Yang; Shang, Jingwei; Ohta, Yasuyuki; Yan, Hongjing; Liu, Xia; Li, Xianghong; Morihara, Ryuta; Nakano, Yumiko; Fukui, Yusuke; Shi, Xiaowen; Huang, Yong; Feng, Tian; Takemoto, Mami; Sato, Kota; Hishikawa, Nozomi; Yamashita, Toru; Abe, Koji.

In: Journal of Stroke and Cerebrovascular Diseases, 01.01.2018.

Research output: Contribution to journalArticle

Jiao, Yang ; Shang, Jingwei ; Ohta, Yasuyuki ; Yan, Hongjing ; Liu, Xia ; Li, Xianghong ; Morihara, Ryuta ; Nakano, Yumiko ; Fukui, Yusuke ; Shi, Xiaowen ; Huang, Yong ; Feng, Tian ; Takemoto, Mami ; Sato, Kota ; Hishikawa, Nozomi ; Yamashita, Toru ; Abe, Koji. / Neuroprotective Effects of Tocovid Pretreatment in a Mouse Stroke Model. In: Journal of Stroke and Cerebrovascular Diseases. 2018.
@article{5b0368f42d44403d86bc4456d27e459c,
title = "Neuroprotective Effects of Tocovid Pretreatment in a Mouse Stroke Model",
abstract = "Background: Tocovid is a new combination of tocotrienols and tocopherol, both of which are neuroprotective agents for preventing cerebral infarction in mice. However, the effects of tocovid on anti-inflammation in ischemic model remain elusive. In the present study, we assessed the effects of Tocovid pretreatment on anti-inflammatory effects after transient middle cerebral occlusion (tMCAO) in mice. Materials and Methods: We evaluated the therapeutic and anti-inflammatory effects of tocovid pretreatment (200 mg/kg per day, for 1 month) on mice brain under 60 minutes of tMCAO. The expressive changes of inflammatory markers were observed after tMCAO in mice. Results: Tocovid pretreatment greatly improved the mice neurobehaviors, reduced infarct volumes and decreased expressions of inflammatory markers such as tumor necrosis factor-α (TNF-α), monocyte chemotactic protein-1 (MCP-1) and ionized calcium binding adapter molecule-1 (Iba-1), and improved the damage of neurovascular units including matrix metallopeptidase 9, IgG and collagen IV after tMCAO. Conclusions: Our present findings demonstrated that oral tocovid pretreatment showed obviously neuroprotective and at least in part by anti-inflammatory effects in ischemic mice brain.",
keywords = "Neuroinflammation, neurovascular unit dissociation, tocovid, transient middle cerebral occlusion",
author = "Yang Jiao and Jingwei Shang and Yasuyuki Ohta and Hongjing Yan and Xia Liu and Xianghong Li and Ryuta Morihara and Yumiko Nakano and Yusuke Fukui and Xiaowen Shi and Yong Huang and Tian Feng and Mami Takemoto and Kota Sato and Nozomi Hishikawa and Toru Yamashita and Koji Abe",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.jstrokecerebrovasdis.2018.03.014",
language = "English",
journal = "Journal of Stroke and Cerebrovascular Diseases",
issn = "1052-3057",
publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - Neuroprotective Effects of Tocovid Pretreatment in a Mouse Stroke Model

AU - Jiao, Yang

AU - Shang, Jingwei

AU - Ohta, Yasuyuki

AU - Yan, Hongjing

AU - Liu, Xia

AU - Li, Xianghong

AU - Morihara, Ryuta

AU - Nakano, Yumiko

AU - Fukui, Yusuke

AU - Shi, Xiaowen

AU - Huang, Yong

AU - Feng, Tian

AU - Takemoto, Mami

AU - Sato, Kota

AU - Hishikawa, Nozomi

AU - Yamashita, Toru

AU - Abe, Koji

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Background: Tocovid is a new combination of tocotrienols and tocopherol, both of which are neuroprotective agents for preventing cerebral infarction in mice. However, the effects of tocovid on anti-inflammation in ischemic model remain elusive. In the present study, we assessed the effects of Tocovid pretreatment on anti-inflammatory effects after transient middle cerebral occlusion (tMCAO) in mice. Materials and Methods: We evaluated the therapeutic and anti-inflammatory effects of tocovid pretreatment (200 mg/kg per day, for 1 month) on mice brain under 60 minutes of tMCAO. The expressive changes of inflammatory markers were observed after tMCAO in mice. Results: Tocovid pretreatment greatly improved the mice neurobehaviors, reduced infarct volumes and decreased expressions of inflammatory markers such as tumor necrosis factor-α (TNF-α), monocyte chemotactic protein-1 (MCP-1) and ionized calcium binding adapter molecule-1 (Iba-1), and improved the damage of neurovascular units including matrix metallopeptidase 9, IgG and collagen IV after tMCAO. Conclusions: Our present findings demonstrated that oral tocovid pretreatment showed obviously neuroprotective and at least in part by anti-inflammatory effects in ischemic mice brain.

AB - Background: Tocovid is a new combination of tocotrienols and tocopherol, both of which are neuroprotective agents for preventing cerebral infarction in mice. However, the effects of tocovid on anti-inflammation in ischemic model remain elusive. In the present study, we assessed the effects of Tocovid pretreatment on anti-inflammatory effects after transient middle cerebral occlusion (tMCAO) in mice. Materials and Methods: We evaluated the therapeutic and anti-inflammatory effects of tocovid pretreatment (200 mg/kg per day, for 1 month) on mice brain under 60 minutes of tMCAO. The expressive changes of inflammatory markers were observed after tMCAO in mice. Results: Tocovid pretreatment greatly improved the mice neurobehaviors, reduced infarct volumes and decreased expressions of inflammatory markers such as tumor necrosis factor-α (TNF-α), monocyte chemotactic protein-1 (MCP-1) and ionized calcium binding adapter molecule-1 (Iba-1), and improved the damage of neurovascular units including matrix metallopeptidase 9, IgG and collagen IV after tMCAO. Conclusions: Our present findings demonstrated that oral tocovid pretreatment showed obviously neuroprotective and at least in part by anti-inflammatory effects in ischemic mice brain.

KW - Neuroinflammation

KW - neurovascular unit dissociation

KW - tocovid

KW - transient middle cerebral occlusion

UR - http://www.scopus.com/inward/record.url?scp=85047238194&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047238194&partnerID=8YFLogxK

U2 - 10.1016/j.jstrokecerebrovasdis.2018.03.014

DO - 10.1016/j.jstrokecerebrovasdis.2018.03.014

M3 - Article

C2 - 29803600

AN - SCOPUS:85047238194

JO - Journal of Stroke and Cerebrovascular Diseases

JF - Journal of Stroke and Cerebrovascular Diseases

SN - 1052-3057

ER -